Kush Parmar Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 months, 1 week ago
Kush Parmar has an estimated net worth of at least $10.7 million*, as of Feb. 5, 2025. They own 1.1 million shares of TRDA stock. They have sold 890,706 shares of TRDA stock since 2021, for an estimated $-5.0 million.
Kush Parmar $TRDA SEC Form 4 Insider Trading
Kush Parmar has filed a total of 1 insider trades in $TRDA since 2021. Their most recent trade was a purchase of 250,000 shares, made on Nov 02, 2021. Their largest trade was a purchase of 250,000 shares, made on Nov 02, 2021. We estimate that they now own 1.1 million shares of $TRDA, worth an estimated $15.7 million.
Insider Trading at $TRDA
There have been a total of 194 insider trades reported at $TRDA since 2021, with 2.0 million shares purchased and 501,630 shares sold. The most active insider traders in $TRDA stock have been Dipal Doshi, Kory James Wentworth, and Nerissa Kreher. The most recent trade was a sale of 1,784 shares reported by KORY JAMES WENTWORTH (Chief Financial Officer), made on Mar 17, 2025.
History of Insider Stock Trades by Kush Parmar
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
RLYB
|
Sale | 100,000 | Mar 07, 2023 | March 9, 2023, 5:39 p.m. |
|
RLYB
|
Sale | 50,329 | Jun 03, 2022 | June 7, 2022, 5:03 p.m. |
|
RLYB
|
Sale | 99,671 | Jun 03, 2022 | June 7, 2022, 5:03 p.m. |
|
RLYB
|
Sale | 33,553 | May 23, 2022 | May 25, 2022, 6:34 p.m. |
|
RLYB
|
Sale | 66,447 | May 23, 2022 | May 25, 2022, 6:34 p.m. |
|
RLYB
|
Sale | 70,461 | Feb 08, 2022 | Feb. 10, 2022, 7:22 p.m. |
|
RLYB
|
Sale | 139,539 | Feb 08, 2022 | Feb. 10, 2022, 7:22 p.m. |
VOR
|
Sale | 91,836 | Nov 16, 2021 | Nov. 18, 2021, 9:10 p.m. |
|
VOR
|
Sale | 238,870 | Nov 16, 2021 | Nov. 18, 2021, 9:10 p.m. |
TRDA
|
Purchase | 250,000 | Nov 02, 2021 | Nov. 4, 2021, 8 p.m. |
|
RLYB
|
Purchase | 615,384 | Aug 02, 2021 | Aug. 3, 2021, 8 p.m. |
$TRDA Executives and Stock Owners with Insider Trades
-
Dipal Doshi, President and CEO
-
Kory James Wentworth, Chief Financial Officer
-
Nerissa Kreher, Chief Medical Officer
-
Nathan J Dowden, Chief Operating Officer
-
Natarajan Sethuraman, Chief Scientific Officer
-
Natarajan Sethuraman, President, Research & Develop.
-
Dipal Doshi, CEO
-
Nathan J Dowden, President & COO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.